Johnson Controls International PLC stock underperforms Thursday when compared to competitors
Johnson Controls International PLC closed 15.01% short of its 52-week high of $91.14, which the company achieved on February 18th.
News Medical on MSN18h
New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer
Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic ...